More than two-thirds of drug OD deaths in 2017 involved opioids

More than two-thirds of drug OD deaths in 2017 involved opioids
(HealthDay)—More than two-thirds of drug overdose deaths in 2017 involved an opioid, with increases in overdose deaths from all opioids and synthetic opioids seen from 2016 to 2017, according to research published in the Dec. 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Lawrence Scholl, Ph.D., from the CDC in Atlanta, and colleagues examined state-level changes in death rates involving in 50 states and the District of Columbia (DC) and those involving synthetic opioids in 20 states for 2013 to 2017. The changes in death rates during 2016 to 2017 involving opioids and opioid subcategories were also examined.

The researchers found that 67.8 percent of the 70,237 drug in 2017 involved an opioid. There was an increase in drug overdose death rates in 35 of 50 states and in DC from 2013 to 2017; in 15 of 20 states, significant increases in involving synthetic opioids occurred, likely driven by illicitly manufactured fentanyl. Overdose deaths involving opioids and synthetic opioids increased from 2016 to 2017; deaths involving prescription opioids and heroin remained stable.

"Through 2017, the drug overdose epidemic continues to worsen and evolve, and the involvement of many types of drugs (e.g., opioids, cocaine, and methamphetamine) underscores the urgency to obtain more timely and local data to inform and public safety action," the authors write.


Explore further

Naloxone rarely administered by layperson in opioid deaths

More information: Abstract/Full Text

Copyright © 2018 HealthDay. All rights reserved.

Citation: More than two-thirds of drug OD deaths in 2017 involved opioids (2018, December 28) retrieved 16 January 2019 from https://medicalxpress.com/news/2018-12-two-thirds-drug-od-deaths-involved.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more